Dare Bioscience (DARE) Misses Q3 EPS by 55c

Dare Bioscience (NASDAQ: DARE) reported Q3 EPS of ($0.55). Revenue for the quarter came in at $41.69 million.

For earnings history and earnings-related data on Dare Bioscience (DARE) click here.

You May Also Be Interested In

• Is Treasury selloff a major issue for stock market bulls?
• DA Davidson Reiterates Buy Rating on Boost Run (BRUN)
• Yum! Brands (YUM) PT Lowered to $180 at Argus